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 At least eleven crystallin genes encode over 95% of the
water-soluble structural proteins present in the crystalline lens
[1], representing >30% of its mass [2], and accounting for its
optical transparency [3] and high refractive index [4,5]. These
genes may be divided into two distinct evolutionary groups
comprising two α-crystallins (CRYAA and CRYAB), which are
members of the small heat shock family of molecular chaper-
ones, and nine β-/γ-crystallins (CRYBA1/A3/A4/B1/B2/B3 and
CRYGC/D/S) which share a common two-domain structure
composed of Greek-key motifs, and belong to the family of
epidermis-specific differentiation proteins [2]. Because of their
abundant expression in the lens, crystallin genes represent
compelling candidates for certain hereditary forms of lens
opacity, or cataract, that usually present at birth (congenital)
or during infancy and which represent a clinically significant
cause of vision impairment in childhood [6].
Presently, Online Mendelian Inheritance in Man lists at
least sixteen mutations affecting eight human crystallin genes
that have been associated with non-syndromic forms of Men-
delian cataract, most often exhibiting autosomal dominant
transmission. Clinical descriptions of these crystallin-related
cataracts have revealed considerable interfamilial variation
with respect to the physical location and appearance of opaci-
ties in different developmental regions of the juvenile lens
[7,8]. Thus, missense and nonsense mutations in CRYAA on
21q have been linked with central nuclear cataract [9,10] and
autosomal recessive cataract [11], and a deletion mutation in
CRYAB on 11q underlies posterior polar cataract [12]. A splice-
site mutation in CRYBA3/A1 on 17q has been associated with
sutural cataract [13-15], whereas nonsense mutations in
CRYBB1 and CRYBB2 on 22q have been linked with pulveru-
lent cataract [16,17], cerulean cataract [18], and sutural cata-
ract [19]. Finally, insertion and missense mutations in CRYGC
on 2q have been linked with zonular pulverulent cataract
[20,21] and lamellar cataract [22], whereas, missense and non-
sense mutations in neighboring CRYGD underlie aculeiform
cataract [20,23], crystal cataract [24], progressive punctate
cataract [25], lamellar and central nuclear cataract [22], cer-
ulean cataract [26,27], and flaky, silica-like nuclear cataract
[15].
To gain further insights about the relationship between
crystallin gene mutations and cataract morphology, we have
carried out linkage analysis in a family segregating autosomal
dominant coral-like cataract and subsequently identified a
missense mutation in CRYGD.
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Purpose: Hereditary cataract is a clinically and genetically heterogeneous lens disorder that usually presents as a sight-
threatening trait in childhood. The purpose of this study was to map and identify the mutation underlying an autosomal
dominant form of coral-shaped cataract segregating in a three generation Caucasian pedigree.
Methods: Genomic DNA was prepared from blood leucocytes, genotyping was performed using microsatellite markers,
and LOD scores were calculated using the LINKAGE programs. Mutation detection was performed using direct sequenc-
ing and primer extension analysis. Following site-directed mutagenesis, mutant and wild type expression constructs were
transfected into a human lens epithelial cell line (HLE B-3) and recombinant protein was detected by immunoblotting,
imunofluorescence, and immunogold microscopy. Cell death was monitored by fluorescence activated cell sorting.
Results: Significant evidence of linkage was detected at markers D2S371 (LOD score [Z]=3.81, recombination fraction
[θ]=0) and D2S369 (Z=3.64, θ=0). Haplotyping indicated that the disease gene lay in the approximate 10 Mb physical
interval between D2S1384 and D2S128, containing the γ-crystallin gene (CRYGA-CRYGD) cluster on chromosome 2q33.3-
q34. Sequencing of the CRYGA-CRYGD cluster identified a C->A transversion in exon 2 of CRYGD that was predicted to
result in the non-conservative substitution of threonine for proline at amino-acid residue 23 (P23T) in the processed
CRYGD protein. Transfection studies suggested that the P23T mutant was less soluble than its wild type counterpart when
expressed in HLE B-3 cells.
Conclusions: This study has identified an eighth type of cataract morphology associated with CRYGD and suggests that
a CRYGD mutation may underlie the historically important “coralliform” cataract first reported in 1895.
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METHODS
Genotyping and linkage analysis:  Genomic DNA was ex-
tracted from peripheral blood leukocytes using the QIAamp
DNA blood maxi kit (Qiagen, Valencia, CA) and Généthon
microsatellite (CA)
n
 repeat markers [28] were amplified us-
ing the polymerase chain reaction (PCR) and detected using a
Li-Cor 4200 DNA analyzer running Gene ImageR software
(Li-Cor, Lincoln, NE) as described previously [10]. Pedigree
and haploptype data were managed using Cyrillic (version 2.1)
software (FamilyGenetix Ltd., Reading, United Kingdom) and
two point LOD scores (Z) calculated using the MLINK sub-
program from the LINKAGE (version 5.1) package of pro-
grams [29]. Microsatellite marker allele frequencies used for
linkage analysis were those calculated by Généthon [28]. A
gene frequency of 0.0001 and a penetrance of 100% were as-
sumed for the cataract locus.
Mutation analysis:  Exon/intron boundaries in CRYGA-
CRYGD were identified using the Ensembl human genome
browser. Gene-specific PCR primers (Table 1) were designed
to anneal to intronic sequence flanking exon boundaries. Ge-
nomic DNA was PCR amplified, purified and direct sequenced
using dye-terminator chemistry as described previously [10].
Primer extension analysis was performed using wild type and
mutant allele-specific primers (Table 1) and the resulting PCR
products separated and visualized in 2% agarose gels contain-
ing 0.05% ethidium bromide. In order to distinguish the pre-
dicted mutation, with 95% confidence, from a polymorphism
with 1% frequency we carried out primer extension analysis
or direct sequencing of genomic DNA samples from a panel
of 170 unrelated control individuals as recommended previ-
ously [30].
Expression construct and site-directed mutagenesis:  To-
tal RNA was isolated from human postmortem lenses using
Trizol (Invitrogen, Carlsbad, CA) and cDNA was reverse tran-
scribed in the presence of random hexamers then amplified
using the GeneAmp RNA PCR kit (Roche, Indianapolis, IN)
and the following CRYGD-specific primers flanking the trans-
lation start (ATG) and stop (TGA) codons; sense 5'-GCC ACC
ATG GGG AAG ATC ACC CTC TAC G and anti-sense 5'-
TTA TCA GGA ATC TAT GAC TCT CCT CAG. The result-
ing wild type CRYGD coding sequence (528 bp) was sub-
cloned into the pcDNA3.1 mammalian expression vector
(Invitrogen) and verified by sequencing using the T7 sequenc-
ing primer. Site-directed mutagenesis of wild type CRYGD
was performed using the QuikChange Mutagenesis kit
(Stratagene, La Jolla, CA) and verified by sequencing prior to
transfection. Sequences of the complementary sense and anti-
sense primers used to introduce the C->A mutation at the first
nucleotide of codon 24 were; 5'-TGC AGC AGC GAC CAC
ACC AAC CTG CAG CCC and 5'-GGG CTG CAG GTT GGT
GTG GTC GCT GCT GCA, respectively.
Cell culture and transfection:  Human lens epithelial cells
with extended life span (HLE B-3) were cultured, transfected,
selected, and expanded as described previously [31-33].
Immunoblot analysis:  Quantitative immunoblot analysis
was performed as described previously [32,34] using an anti-
serum (diluted 1:1,000) raised against bovine γ-crystallins [35]
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Figure 1. Pedigree and haplotype analysis of the cataract family.  Four-
generation pedigree segregating autosomal dominant coral-like cata-
ract. Haplotyping shows segregation of five microsatellite markers
on 2q listed in descending order from the centromere. Squares and
circles symbolize males and females respectively. Blackened sym-
bols and bars denote afffected status.
TABLE 1. PCR PRIMERS FOR MUTATION SCREENING OF CRYGA-
CRYGD ON 2Q
Gene (Exon)    Strand          Sequence (5'-3')
-----------   ---------   ---------------------------
CRYGA (1-2)   Sense       TCCCTTTTGTGTTGTTTTTGCC
              Antisense   TATGGCCATGGATCATTGATGC
CRYGA (3)     Sense       TCGTTGACACCCAAGGATGCATGC
              Antisense   TACAAGAGCCACTTAGTGCAGGG
CRYGB (1-2)   Sense       TGCAAATCCCCTACTCACCAAAATGG
              Antisense   TAAAAGATGGAAGGCAAAGACAGAGCC
CRYGB (3)     Sense       TAGGGACTGGAGCTTTAATTTCC
              Antisense   TACTAGTGCCAGAAACACAAGC
CRYGC (1-2)   Sense       TGCAGGATGTTAAGAGATGC
              Antisense   TTCTCTGATGTCCATCTAAGC
CRYGC (3)     Sense       TATTCCATGCCACAACCTACC
              Antisense   TTGACAGAAGTCAGCAATTGC
CRYGD (1-2)   Sense       TCTTTTGTGCGGTTCTTGCCAACG
              Antisense   TACCATCCAGTGAGTGTCCTGAGG
              Mutant      TCAAGTAGGGCTGCAGGTTGGT
CRYGD (3)     Sense       TCTTTTTATTTCTGGGTCCGCC
              Antisense   TACAAGCAAATCAGTGCCAGG
Primer pairs used for amplification and sequencing of exons from
the CRYGA-CRYGD gene cluster located on chromosome 2q.
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and horseradish peroxidase-labelled goat-ant-rabbit IgG, then
detected by chemiluminescence using Luminol reagent (Santa
Cruz Biotechnology, Santa Cruz, CA) and X-ray film (Eastman
Kodak Co., Rochester, NY). Blots were re-probed with beta-
tubulin antibody (Sigma, St. Louis, MO) to confirm equal load-
ing of samples.
Immunofluorescence microscopy:  Transfected cells were
fixed, permeabilized and immunostained with γ-crystallin an-
tiserum (1:5,000) followed by an Alexa488-conjugated goat
anti-rabbit IgG (Molecular Probes, Eugene, OR) and Texas
Red-phalloidin (Molecular Probes) as described previously
[34] then viewed under a confocal microscope (Zeiss LSM
510, Thornwood, NY).
Cryo-immunoelectron microscopy:  Transfected cells were
fixed, embedded, cryo-preserved, sectioned and incubated with
γ-crystallin antiserum (1:5,000) followed by goat anti-mouse
IgG conjugated with 18 nm gold particles (Sigma), then stained
and viewed under a transmission electron microscope
(JEOL1200EX, Peabody, MA) as described previously [10].
Fluorescence activated cell sorting (FACS) analysis:
Transfected cells were labeled with Annexin V-FITC and
propidium iodide (Pharmingen, San Diego, CA), and the per-
centage of apoptotic cells quantified by flow cytometry using
a FACScan running CellQuest software (Becton Dickinson,
San Jose, CA) as described previously [33].
RESULTS
Linkage analysis:  We ascertained a three-generation Cauca-
sian family segregating autosomal dominant cataract in the
absence of other ocular or systemic abnormalities (Figure 1).
No clinical photographs of the lens opacities were available,
however, ophthalmic records indicated that the bilateral cata-
ract presented during infancy and was described as coralliform
or axial [36-38], having long trumpet-shaped opacities grouped
toward the center of the lens and projecting radially forward
resembling a piece of coral. This study was approved by the
institutional review board at Washington University School
of Medicine and all participants provided informed consent
prior to enrollment.
Seventeen members of the family including seven affected
individuals, eight unaffected individuals, and two spouses were
genotyped with microsatellite markers [28] at five crystallin
loci linked with autosomal dominant cataract on 2q, 11q, 17q,
21q, and 22q. Following exclusion of four of these loci, we
obtained significant evidence of linkage (Table 2) for markers
D2S371 (Z=3.81, θ=0) and D2S369 (Z=3.64, θ= 0) on 2q33.3-
q34.
Haplotyping of the pedigree (Figure 1) detected one af-
fected male (IV:3) and one unaffected female (II:4) who were
obligate recombinants at D2S128 and at D2S1384, respec-
tively. However, no recombinant individuals were detected at
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Figure 2. Mutation analysis of CRYGD.  Sequence chromatograms
of the wild type allele (A) showing translation of proline (CCC) and
the mutant allele (B) showing a C->A transversion that substituted
threonine (ACC) for proline at amino-acid position 23 (P23T). C:
Agarose-gel electrophoresis of allele-specific primer extension prod-
ucts generated using the three PCR primers (Table 1) indicated by
arrows in the schematic diagram; the sense anchor primer was lo-
cated in the 5'-upstream region, the antisense primer was located in
intron 2 and the nested mutant primer was specific for the A-allele.
Unaffected relatives are homozygous for the wild type C-allele (535
bp), whereas, affected relatives are heterozygous for the mutant A-
allele (322 bp). The letter M designates a 100 bp size ladder. D: Exon
organization and mutation profile of CRYGD. Codons and correspond-
ing Greek-key protein domains are numbered above each exon. The
relative locations of the P23T mutation and four other mutations as-
sociated with cataract in humans are indicated. Mutations are num-
bered according to their amino-acid position in the processed CRYGD
protein, which lacks an N-terminal methionine.
TABLE 2. TWO-POINT LOD SCORES FOR LINKAGE BETWEEN THE
CATARACT LOCUS AND 2Q MARKERS
                                   Z at θ=
                  -----------------------------------------
Marker     Mb     0.00    0.05    0.1    0.2    0.3    0.4    Z(max)   θ(max)
-------   -----   -----   -----   ----   ----   ----   ----   ------   ------
D2S1384   205.2     -∞      1.87   1.89   1.59   1.10   0.51    1.91     0.08
D2S369    207.4    3.64    3.31   2.96   2.20   1.37   0.53    3.64     0.00
D2S157    211.1    0.60    0.54   0.47   0.32   0.17   0.05    0.60     0.00
D2S371    212.3    3.81    3.47   3.12   2.37   1.53   0.66    3.81     0.00
D2S128    215.0   -0.86    2.22   2.20   1.78   1.17   0.50    2.24     0.07
D2S2248   217.9     -∞     -0.56   0.07   0.38   0.28   0.05    0.38     0.21
Two point LOD scores (Z) for linkage between the cataract locus
and six markers on 2q listed in physical order from 2p-tel, measured




 are denoted by Z(max)
and θ(max), respectively.
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three other intervening markers, suggesting that the cataract
locus lies in the 9.8 Mb physical interval, D2S1384-(2.2 Mb)-
D2S369-(3.7 Mb)-D2S157-(1.2 Mb)-D2S371-(2.7 Mb)-
D2S128, which spanned the γ-crystallin gene cluster (CRYGA-
CRYGF), but excluded the gene for βA2-crystallin (CRYBA2).
Mutation analysis:  Four functional candidate genes
(CRYGA-CRYGD), and two pseudogenes (CRYGE-F) with in-
frame translation stop codons, are clustered within the physi-
cal region defined for the cataract on 2q (Ensembl). We sys-
tematically sequenced all four functional CRYG genes, each
comprising 3 exons and 2 introns (Figure 2D), in two affected
and two unaffected members of the family using intron spe-
cific primers (Table 1). In addition to five single nucleotide
polymorphisms (SNPs) referenced as rs796280, rs2854723,
rs796287, rs2242074, rs2305430 in the NCBI SNP database,
we detected a C->A transversion in exon 2 of CRYGD that
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Figure 3. Expression analysis of CRYGD in HLE-B3 cells.  A:
Immunoblot analysis of detergent-soluble and insoluble fractions from
vector only (Mock), wild type (WT), and mutant (P23T) transfectants,
showing absence of CRYGD antigen (M
r
 20.74 kDa) in Mock
transfectants, equivalent levels of soluble CRYGD in WT and P23T
transfectants (large arrow), and increased levels of insoluble CRYGD
in P23T versus WT transfectants. Small arrows indicate weak immu-
noreactivity of the calf γ-crystallin antiserum with unidentified soluble
proteins. B,C,D: Immunofluorescence confocal microscopy of vec-
tor only (B), wild type (C) and mutant (D) transfectants showing
intense immunostaining (green) of CRYGD, primarily localized to
the cytoplasm in C and D, and absence of significant immunostaining
in B. Texas Red-phalloidin staining of the f-actin cytoskeleton is
shown in red. The bar represents 20 µm. E: FACS analysis showing
relative percentages of apoptotic cells in wild type (WT), mutant
(P23T), and mock (vector only) transfectants.
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was present in both of the affected individuals but not in ei-
ther of the unaffected individuals (Figure 2A). As the C->A
transversion did not result in the gain or loss of a convenient
restriction site, we designed allele-specific primer extension
analysis to confirm that the mutant “A” allele (Table 1) co-
segregated with affected but not with unaffected members of
the family (Figure 2C). Finally, we excluded the C->A trans-
version as a SNP in a panel of 170 normal unrelated individu-
als.
The C->A transversion occurred at the first base of codon
24, counting from the translation start (ATG) codon for me-
thionine, and was predicted to result in a missense substitu-
tion of proline to threonine at amino-acid position 23 of the
processed CRYGD protein, which lacks an N-terminal me-
thionine (P23T). Alignment of the mammalian amino acid
sequences for CRYGA-CRYGD present in the NCBI Protein
Database, using the BLAST algorithm [39] revealed that ei-
ther proline or serine, but never threonine, were conserved at
amino-acid position 23. Although serine and threonine are both
uncharged polar amino acids, the predicted P23T substitution
represented a non-conservative amino-acid change, with the
hydrophobic side-group of proline replaced by the polar (hy-
droxyl) side-group of threonine. Taken overall, the co-segre-
gation of the C->A transition only with affected members of
the pedigree and its absence in 340 normal chromosomes
strongly suggested that the P23T substitution was a causative
mutation rather than a benign SNP in linkage disequilibrium
with the cataract.
Expression studies:  In previous studies we have detected
aberrant nuclear localization and cytotoxicity associated with
a human αA-crystallin mutant when expressed in HLE B-3
cells [10]. In order to detect similar deleterious effects associ-
ated with the P23T substitution in CRYGD we transfected wild
type and mutant CRYGD expression constructs into cultured
HLE B-3 cells, which do not constitutively express signifi-
cant levels of CRYGD transcript [40] or antigen (Figure 3A,B).
Geneticin-resistant HLE-B3 transfectants that were express-
ing either wild type or mutant CRYGD at concentrations rang-
ing between 0.5-2.0 ng/µg soluble protein, as determined by
immunoblotting (Figure 3A), were selected for subsequent
expression studies. Comparatively, the maximal levels of ex-
ogenous CRYGD attained in HLE B-3 transfectants (0.05-
0.2% soluble protein) were 12-50 fold less than the endog-
enous levels of CRYGD (about 2.5% soluble protein) in the
human fetal lens [1]. Clonal transfectants were used for up to
four passages without detectable changes in the levels of ex-
ogenous wild type or mutant CRYGD as determined by
immunoblot analysis. Whereas the levels of mutant and wild
type CRYGD were similar in the soluble protein fraction,
immunoblotting further indicated that the mutant was consid-
erably more abundant than wild type in the insoluble mem-
brane fraction (Figure 3A).
The sub-cellular distribution of wild type versus mutant
CRYGD in HLE B-3 transfectants was compared using im-
munofluorescence confocal microscopy. Figure 3 shows that
immunofluorescent labeling of wild type and mutant CRYGD
was concentrated mainly in the cytoplasm surrounding the cell
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Figure 4. Ultrastructural localization of CRYGD in HLE B-3 cells.
Cryo-immunoelectron microscopy of HLE B-3 cells expressing ei-
ther wild type (A) or mutant (B) CRYGD showing that immuno-
gold labeling (arrows in both panels) was primarily restricted to the
cytoplasm. The arrowhead in B shows a double membrane structure
surrounding immuno-gold particles. The letter N indicates the nucleus.
The bar represents 1.5 µm. The magnification was x50,000.
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nucleus; however, we could not exclude the possibility that
some CRYGD was localized within cell nuclei, as reported
for certain mouse γ-crystallins [41]. To further examine the
sub-cellular localization of CRYGD at the ultrastructural level
we used cryo-immunoelectron microscopy. Figure 4A shows
that the immuno-gold labeling of wild type CRYGD was pri-
marily localized to the cytoplasm, with no significant accu-
mulation in cell nuclei. Similarly, immuno-gold labeling of
mutant CRYGD was mainly cytoplasmic and occasionally
appeared to be associated with single or double membrane
structures (Figure 4B).
To compare the cytotoxic effects of mutant versus wild
type CRYGD we measured the levels of apoptotic cell death
in HLE B-3 transfectants. To quantify apoptosis, cells were
incubated with annexin V (Ax), an inner plasma-membrane
phospholipid binding protein, and propidium iodide (PI), a
chromatin intercalating dye, and the percentage of labeled cells
was determined by fluorescence-activated cell sorting (FACS)
analysis (Figure 3E). Basal levels of cells that were in the early
stages of apoptosis (Ax+/PI-) were similar in mock (vector
only), wild type and mutant CRYGD transfectants indicating
that the mutant was not significantly more cytotoxic than its
wild type counterpart when expressed at the levels attained in
HLE B-3 cells.
DISCUSSION
 “Peculiar coralliform cataract”, so named for the morphologi-
cal resemblance of these lens opacities to sea coral, was first
described in an individual in 1895 [36] and subsequently as
an autosomal dominant trait in three English pedigrees circa
1910 [37,38]. Here, we have identified a missense substitu-
tion (P23T) in processed CRYGD that co-segregated with
autosomal dominant coral-like cataract in a three-generation
Caucasian family. During the course of this study, the same
P23T substitution was independently associated with congeni-
tal lamellar cataract in a father and daughter of Indian descent
[22], congenital cerulean cataract in a five-generation
Morroccan family [26,27], and flaky, silica-like nuclear cata-
ract in a five-generation Australian family [15]. Lamellar and
cerulean forms of cataract are generally regarded as morpho-
logically distinct types of lens opacities [7,8], with the former
affecting a discrete opacified shell within an otherwise clear
lens, whereas, the latter is characterized by blue-white dots in
the outer nucleus progressing to wedge-shaped opacities in
the cortex. No clinical photographs of the flaky, silica-like
nuclear cataract were published [15], however, close inspec-
tion of the photographs of lamellar cataract in a three year old
patient [22] and cerulean cataract in thirty-five and forty-five
year old patients [26] does reveal striking resemblances to the
original drawing of coralliform cataract in a twenty-two year
old patient published in 1895 [36].
In addition to the P23T substitution, three other missense
substitutions and one nonsense termination in CRYGD have
been associated with cataract, including aculeiform (needle-
like crystals) cataract (R58H) in Macedonian and Swiss fami-
lies [20,23], progressive pulverulent (punctate) cataract (R14C)
in an American family [25], crystal-related cataract [R36S] in
a five year old Czech boy [24], and central nuclear cataract
(W156X) in a father and daughter of Indian descent [22]. Thus,
like the cerulean, coralliform, and flaky opacities associated
with the P23T substitution, these other CRYGD-related opaci-
ties involve the central nucleus of the lens and may also pro-
gressively affect the outer cortex.
Based on the crystal structure of human CRYGD, the P23T
substitution lies in the N-terminal domain within the first
Greek-key motif [42]. Molecular modeling data [27] has indi-
cated that proline 23 interacts with asparigine 49 in wild type
CRYGD, whereas, threonine 23 interacts with asparigine 49
and tyrosine 50 in mutant CRYGD. However, the deleterious
effects of threonine 23 on CRYGD folding, stability, and solu-
bility are unclear especially when serine, which is structurally
similar to threonine, can replace proline 23 as the wild type in
other species. Interestingly, biophysical studies of three other
CRYGD missense substitutions (R14C, R36S, R58H) have
detected deleterious gain-of-function effects, which manifest
as insolubility and/or crystal nucleation in the absence of sig-
nificant protein conformational changes. Thus, the R14C mu-
tant, associated with progressive punctuate cataract, forms
disulfide-linked oligomers in vitro culminating in aggrega-
tion of this normally monomeric protein [43], whereas, the
R36S and R58H mutants, associated with crystal-like and
aculeiform cataract, respectively, promote deposition of
CRYGD-protein crystals in vitro [42,44] and in the lens
[20,23,24]. Remarkably, iridescent crystals were also observed
throughout the clearer part of the lens in the original 1895
description of coralliform cataract [36]. Although we did not
observe crystal-formation by the recombinant P23T mutant
when expressed in cultured HLE B-3 cells, possibly as a re-
sult of the relatively low level of CRYGD protein compared
with that in the lens, there was evidence of membrane-associ-
ated insolubility. Biophysical studies of the P23T mutant, and
others (e.g., P23S), will be required to provide further insights
regarding the molecular pathology of CRYGD-related cata-
ract.
Finally, it is noteworthy that an autosomal dominant
coralliform cataract mutation (Coc) has also been reported in
the mouse [45]. Although no Coc mouse lens photographs were
published the cataract was described as having small, round
irregularly shaped opacities resembling corals located in the
fetal nucleus. Thus, despite the significant morphological dif-
ferences between mouse and human lenses the coralliform
phenotype appears remarkably consistent. The Coc locus has
been linked to a region of murine chromosome 16 with con-
served synteny to a region of human chromosome 3 [46]. In-
terestingly, this linkage excluded as causative the murine γ-
crystallin gene cluster (Cryga-Crygf), which maps to chro-
mosome 1. In addition, the murine γS-crystallin gene (Crygs),
which harbors the opacity due to poor secondary fiber junc-
tions (Opj) mutation [47] located about 20 centi-Morgans
proximal to Coc on chromosome 16, was also excluded as
causative [46]. Identification of the Coc gene will provide novel
insights regarding coralliform cataract in mice and raises the
possibility of genetic heterogeneity for this peculiar type of
hereditary cataract in humans.
©2004 Molecular VisionMolecular Vision 2004; 10:155-62 <http://www.molvis.org/molvis/v10/a21>
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